PF-Atlas › Clinical Trials › NCT02803944

Continuous Azithromycin in Cystic Fibrosis Patients Beyond Two Years

Azithromycin · Not specified

Registry ID
NCT02803944
Phase
Not specified
Status
Completed
Drug / intervention
Azithromycin
Sponsor
Hospices Civils de Lyon
Start
2014-09

About this trial

Azithromycin is evaluated in NCT02803944, a idiopathic pulmonary fibrosis study sponsored by Hospices Civils de Lyon. Current status: Completed.

View NCT02803944 on ClinicalTrials.gov →

Explore related

All Azithromycin trialsAll IPF trials

Related trials

azithromycin — NCT02173145Azithromycin — NCT01270074Azithromycin — NCT05842681Azithromycin — NCT02960503Azithromycin — NCT02003911
Medical disclaimer. This page summarizes public trial data for NCT02803944 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.